Results 31 to 40 of about 4,241 (177)

Recurrent Trans-Sphincteric Ano-Scrotal Fistula Cured by Kshar Sutra Treatment

open access: yesWorld Journal of Colorectal Surgery
Fistula-in-ano (FIA) with scrotal extension is a rare condition. Because symptoms such as swelling, pain, and discharge are common to several diseases, an ano-scrotal fistula may be misdiagnosed as tuberculosis, a sexually transmitted infection, or Crohn’
Prasad Bapat   +2 more
doaj   +1 more source

Transrectal Ultra Sonography based evidence of Ksharasutra therapy for Fistula-in-ano – A case series

open access: yesJournal of Ayurveda and Integrative Medicine, 2017
Ksharasutra (parasurgical procedure using a thread treated by alkalies) is being practiced in Indian system of medicine since ancient time for management of ano-rectal disorders; particularly for Bhagandara, (fistula in ano), and generally difficult to ...
Aditya Nema   +3 more
doaj   +1 more source

A Composite Seton for the Management of Fistula in Ano

open access: yesJournal of Coloproctology
Treatment of fistula in ano by seton has become less in vogue due to the complications and disadvantages associated with its use. In its place, more technically demanding and expensive procedures, with less morbidity but more recurrence, such as ...
Sujith Philip   +2 more
doaj   +1 more source

Japanese Practice Guidelines for Anal Disorders II. Anal fistula

open access: yesJournal of the Anus, Rectum and Colon, 2018
Anal fistulas usually result from an anal gland infection in the intersphincteric space, which is caused by bacteria entering through the anal crypt (cryoptglandular infection). Reports of anal fistulas have been as high as 21 people in 100,000.
Tetsuo Yamana
doaj   +1 more source

Management of Complex Fistula-in-ano by Interception of Fistula Track with Application of Ksharasutra (IFTAK): A Novel Technique

open access: yesJournal of Coloproctology, 2022
Objective Despite all the technological advances, successful management of complex fistula-in-ano is still a challenge due to recurrence and incontinence.
Manoranjan Sahu, Ashish Sharma
doaj   +1 more source

The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 5, May 2026.
ABSTRACT Background The evidence gap relating to the risk of congenital anomalies (CA) associated with first trimester medication exposure in pregnancy is well recognized. Aims We describe the EUROmediCAT network and databases, and the methodological approach to pregnancy pharmacovigilance.
Helen Dolk   +27 more
wiley   +1 more source

Mucosal Advancement Flap for Fistula-in-ano: A Single-Institution Experience

open access: yesWorld Journal of Colorectal Surgery, 2018
Background and Objective: Mucosal advancement flap (MAF) is a well-described definitive treatment for complex fistula-in-ano, with high healing rates ranging from 37 to 87% for cryptoglandular fistula, but with mild incontinence rates of up to 35%. There
Yui Kaneko   +3 more
doaj   +1 more source

The Ligation of Intersphincteric Fistula Tract Technique: A Preliminary Experience [PDF]

open access: yesAnnals of Coloproctology, 2019
Purpose Surgery is the only treatment for anal fistula. Many surgical techniques have been described. The aim of this study was to communicate the authors’ preliminary experience in the use of a recently proposed, simplified technique. Methods This was a
Pasquale Cianci   +5 more
doaj   +1 more source

Treatment Outcomes of Presacral Pilonidal Sinus Disease Using Crystallised Phenol: A Single‐Centre Clinical Series

open access: yesInternational Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Objective: To evaluate short‐term treatment outcomes and treatment burden in patients with presacral pilonidal sinus disease managed with crystallised phenol in a single‐centre clinical series, with particular emphasis on the relationship between pit burden and session requirement. Methods: Consecutive patients treated with crystallised phenol
Berkan Acar   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy